PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:33 AM ET

Sponsor Check › Person

GB
No photo found yet (own website and image search run after this page is viewed)

GARY BREAM

Named as an officer, director or promoter on SEC Form D filings · NC · Sep 8, 2010 → Oct 9, 2013

3deals (issuers)
$10.5Mreported sold
38investors
6Form D filings
2010–2013years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:22 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

GARY BREAM is listed as an executive officer and director on 6 SEC Form D filings by 3 issuers between Sep 2010 and Oct 2013: AERIAL BIOPHARMA, LLC (Morrisville, NC — pharmaceuticals — 2011–2013; $9.5M reported sold to 31 investors), Neuronex, Inc. (Morrisville, NC — pharmaceuticals — 2010–2011; $850K reported sold to 6 investors) and SOLAS PHARMA, LLC (Morrisville, NC — pharmaceuticals — 2011; $200K reported sold to 1 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 3 years. Across those companies the filings report $10.5M sold in total.

Listed alongside Moise Khayrallah (6 shared filings), Stephen Butts (6 shared filings), Clayton Duncan (2 shared filings) and David Adair (1 shared filing).

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around GARY. Each name links to their own page.

All 3 issuers belong to the sponsor group Neuronex (3 issuers, $10.1M reported sold, 2010–2013).

What this means A sponsor group is one team that sets up a new company for each deal. Neuronex has 3 companies on file and $10.1M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 3 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.

What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 6 public filings for GARY BREAM and found 5 differences, 1 worth asking the sponsor about: 4 filings report more than 10% of the money raised going to insiders; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for GARY BREAM has not run yet — it is joining a line of 23,984 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

3 cases: 1 closed (disposition not in docket feed), 1 dismissed, 1 judgment

BREAM v. VEP HEALTHCARE, INC. closed
District Court, M.D. North Carolina · No. 1:21-cv-00554 · Filed Jul 6, 2021 · Closed May 20, 2022
Role of BREAM: Plaintiff · Outcome: Terminated 2022-05-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 5 federal dockets); surname only in the caption; court in the person's filing state (NC)
Watson-Bream v. SmithKline Beecham Corporation dismissed
District Court, E.D. Missouri · No. 4:15-cv-01834 · Filed Dec 11, 2015 · Closed Jun 23, 2016 · Nature of suit: 367 Health care / pharm
Role of Watson-Bream: Plaintiff · Outcome: Terminated 2016-06-23 — FJC Integrated Database disposition: Dismissed: other Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 5 federal dockets); different first name (watson); court in MO (not a filing state)
Bream Orchards, LLC v. Collins Produce, Inc. judgment
District Court, M.D. Florida · No. 8:11-cv-02113 · Filed Sep 16, 2011 · Closed Jan 9, 2012 · Nature of suit: Agriculture Acts · Cause: 07:0499 Agricultural Commodities Act
Role of Bream Orchards, LLC: Plaintiff · Outcome: Terminated 2012-01-09 — FJC Integrated Database disposition: Judgment on default; judgment for plaintiff Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 5 federal dockets); surname only in the caption; court in FL (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched GARY BREAM..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

2 cases: 2 closed (disposition not in docket feed)

O'Fallon Crossing Estate Corporation v. Bream closed
United States Bankruptcy Court, E.D. Missouri · No. 07-04351 · Filed May 18, 2007 · Closed Jul 31, 2007
Role of Bream: Defendant · Outcome: Case closed 2007-07-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 5 federal dockets); surname only in the caption; court in MO (not a filing state)
Gary Lee Bream closed
United States Bankruptcy Court, S.D. Alabama · No. 02-12774 · Filed May 17, 2002 · Closed Jul 3, 2006
Role of Gary Lee Bream: Debtor · Outcome: Case closed 2006-07-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 5 federal dockets); different first name (lee); court in AL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:22 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

5 differences found between the filings for GARY BREAM — 1 worth asking about (compared 6 filings on Oct 24, 2026)

Note · May 18, 2007 – Jul 31, 2007

Bankruptcy case: O'Fallon Crossing Estate Corporation v. Bream — filed May 18, 2007

United States Bankruptcy Court, E.D. Missouri docket "O'Fallon Crossing Estate Corporation v. Bream" filed May 18, 2007, closed Jul 31, 2007. GARY BREAM is listed as Defendant ("Bream"). Our match estimate: 40%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, E.D. Missouri ↗
Sources
Worth asking · Sep 8, 2010 – Oct 11, 2012

4 filings report more than 10% of the money raised going to insiders

75% of the money raised went to insiders — SOLAS PHARMA, LLC · 34% of the money raised went to insiders — Neuronex, Inc. · 40% of the money raised went to insiders — Neuronex, Inc. · 12% of the money raised went to insiders — AERIAL BIOPHARMA, LLC

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Jun 2, 2011 ↗SOLAS PHARMA, LLC — PartnerFacts page ↗Form D · May 6, 2011 ↗Neuronex, Inc. — PartnerFacts page ↗
Sources
Note · Jun 2, 2011

GARY BREAM appears on 1 deal that stopped filing before reaching its target

SOLAS PHARMA, LLC (last filing Jun 2, 2011; $200,000 sold of $2,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

SOLAS PHARMA, LLC — PartnerFacts page ↗
Sources
Note · Apr 15, 2011 – May 6, 2011

Form D filed 21 days after the first sale — Neuronex, Inc.

The filing says the first sale was Apr 15, 2011. The Form D was filed May 6, 2011 — 21 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 6 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · May 6, 2011 ↗Neuronex, Inc. — PartnerFacts page ↗
Sources
Note · Aug 31, 2010 – Oct 9, 2013

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — AERIAL BIOPHARMA, LLC (latest filing Oct 9, 2013) · No amendment in the last 12 months on an offering that may still be open — SOLAS PHARMA, LLC (latest filing Jun 2, 2011) · No amendment in the last 12 months on an offering that may still be open — Neuronex, Inc. (latest filing May 6, 2011) · No amendment in the last 12 months on an offering that may still be open — Neuronex, Inc. (latest filing Sep 8, 2010)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D/A · Oct 9, 2013 ↗AERIAL BIOPHARMA, LLC — PartnerFacts page ↗Form D · Jun 2, 2011 ↗SOLAS PHARMA, LLC — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 4 offerings report sales commissions; 0 report finder's fees; 4 report proceeds to related persons totalling $1,293,500. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 9, 2013 D/A
AERIAL BIOPHARMA, LLC
File 021-167025
$0$0$670,000 (est.)None listed on this filingEDGAR ↗
Jun 2, 2011 D
SOLAS PHARMA, LLC
File 021-160696
$0$0$150,000 (est.)None listed on this filingEDGAR ↗
May 6, 2011 D
Neuronex, Inc.
File 021-159369
$0$0$135,500 (est.)None listed on this filingEDGAR ↗
Sep 8, 2010 D
Neuronex, Inc.
File 021-147421
$0$0$338,000None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Gary Bream on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

AB
Pharmaceuticals · group: Neuronex

AERIAL BIOPHARMA, LLC

Morrisville, NC · Oct 11, 2011 → Oct 9, 2013 · 3 filings
  • Oct 9, 2013 · D/A · $9,500,000 sold of $12,000,000 · 31 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Oct 11, 2012 · D/A · $5,664,618 sold of $12,000,000 · 23 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Oct 11, 2011 · D · $0 sold of $12,000,000 · 0 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $9.5M from 31 investors (79% of the $12M target) as of the latest filing. Gary is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SP
Pharmaceuticals · group: Neuronex

SOLAS PHARMA, LLC

Morrisville, NC · Jun 2, 2011
  • Jun 2, 2011 · D · $200,000 sold of $2,000,000 · 1 investors · min. $100,000 · role: Executive Officer, Director EDGAR ↗

Raised $200K from 1 investor (10% of the $2M target) as of the latest filing. Gary is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

N
Pharmaceuticals · group: Neuronex

Neuronex, Inc.

Morrisville, NC · Sep 8, 2010 → May 6, 2011 · 2 filings
  • May 6, 2011 · D · $399,999 sold of $1,200,000 · 6 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Sep 8, 2010 · D · $849,999 sold of $1,450,000 · 2 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $850K from 6 investors (71% of the $1.2M target) as of the latest filing. Gary is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Gary 4

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Moise Khayrallah

Executive Officer, Director · 6 shared filings (3 issuers) · also on 3 other issuers

Moise Khayrallah is on 6 issuers in total — a repeat sponsor. Their page lists every one.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Butts

Executive Officer, Director · 6 shared filings (3 issuers) · also on 4 other issuers

Stephen Butts is on 7 issuers in total — a repeat sponsor. Their page lists every one.

CD
No photo found yet (own website and image search run after this page is viewed)
Person

Clayton Duncan

Director, Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Gary Bream. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David Adair

Director · 1 shared filing (1 issuer) · also on 14 other issuers

David Adair is on 15 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

N
Sponsor group

Neuronex

3 issuers · 6 filings · $10.1M reported sold · 2010–2013

One team, 3 deal companies. Gary Bream is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name GARY BREAM.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to GARY BREAM by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Gary Bream is listed on: none on file. No website or social profile named in Neuronex, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #351,900 of 374,652 in line (1,195 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Morrisville, NC). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗North Carolina eCourts portal ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

North Carolina Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when GARY BREAM appears on a new Form D, or when a court case or SEC action is matched to them. See plans →